Lawal, Ismaheel OpeyemiMarcus, CharlesSchuster, David M.Goyal, SubirAdediran, Omotayo A.Dhere, Vishal R.Joshi, Shreyas S.Abiodun-Ojo, Olayinka A.Master, Viraj A.Patel, Pretesh R.Fielder, BridgetGoodman, MarkShelton, Joseph W.Kucuk, OmerHershatter, BruceHalkar, Raghuveer K.Jani, Ashesh B.2023-10-112023-04Lawal, I.O., Marcus, C., Schuster, D.M. et al. 2023, 'Impact of F-18-fluciclovine PET/CT findings on failure-free survival in biochemical recurrence of prostate cancer following salvage radiation therapy', Clinical Nuclear Medicine, vol. 48, no. 4, pp. E153-E159, doi : 10.1097/RLU.0000000000004590.0363-9762 (print)1536-0229 (online)10.1097/RLU.0000000000004590http://hdl.handle.net/2263/92828Please read abstract in the article.en© 2023 Wolters Kluwer Health / Lippincott Williams & Wilkins. This is a non-final version of an article published in final form in Clinical Nuclear Medicine, vol. 48, no. 4, pp. E153-E159, doi : 10.1097/RLU.0000000000004590.18F-fluciclovine PET/CT imagingPositron emission tomography/computed tomography (PET/CT)Failure-free survival (FFS)Salvage radiotherapy (SRT)Prostate cancerSDG-03: Good health and well-beingBiochemical recurrence (BCR)Impact of 18F-fluciclovine PET/CT findings on failure-free survival in biochemical recurrence of prostate cancer following salvage radiation therapyPostprint Article